Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Transnasal Esophagoscopy: Targeting Interventions for a Community That Has Been Targeted for Cancer Risk

NCT05480891 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT05480891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05480891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Transnasal Esophagoscopy: Targeting Interventions for a Community That Has Been Targeted for Cancer Risk
Lead sponsor
University of Illinois at Chicago
Phase
Observational
Overall status
Terminated
Start date
April 5, 2023
Completion date
March 19, 2025
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer